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Dose of the day
Cone Beam CT
a b s t r a c t
Background and purpose: Accurate Cone Beam CT (CBCT) based dose calculations are hindered by limited
CBCT image quality. Using retrospective artefact corrections, this paper investigated the accuracy of dose
calculations performed directly on CBCT images of lung cancer patients.
Materials and methods: Dose calculations were made directly on clinical and artefact corrected CBCT
images of 21 lung cancer patients with a re-simulation CT (rCT) image acquired during radiotherapy.
The original treatment plan was copied to the rCT and CBCT images and dose was recalculated.
Dose comparisons were made using gamma analysis and dose statistics. Gamma comparisons were made
using 2%/2 mm and 1%/1 mm criteria, and pass rates of the clinical and improved CBCT images were
calculated using the rCT based dose as reference.
Results: Dose distributions calculated on the artefact corrected CBCT images had a median 2%/2 mm
gamma pass rate of 99.4% when compared to the reference rCT. Doses calculated on the clinical CBCT
images had a median 2%/2 mm gamma pass rate of 93.1%. Wilcoxon signed rank test showed the pass
rates in the entire CBCT field of view different at p < 0:001. Clinical CBCT image based dose calculations
overestimated the dose, while the improved CBCT doses were in closer agreement with the rCT doses.
Conclusions: Comprehensive artefact correction of CBCT images allowed highly accurate dose calcula-
tions to be performed directly on CBCT images of lung cancer patients, following the standard
CT-based workflow in a treatment planning system.
 2017 The Authors. Published by Elsevier Ireland Ltd on behalf of European Society of Radiotherapy &
Oncology. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
licenses/by-nc-nd/4.0/).
1. Introduction
Over the last decade, research in Cone Beam CT (CBCT) based
adaptive radiotherapy (ART) has seen a growing interest. Different
uses of the three dimensional anatomical information obtained
through CBCT based image guided radiotherapy (IGRT) have
been investigated, such as CBCT based dose calculations [1–5]
and tumour and normal tissue response during fractionated
radiotherapy [6–9].
The one common factor which inhibits the clinical realisation of
CBCT based ART is the image quality of CBCT images. A multitude
of artefacts and lack of proper Hounsfield Unit (HU) calibration
means that the standard tools developed in radiotherapy for use
with fan beam CT images cannot be transferred directly to CBCT
images. Several papers have been published demonstrating how
artefact corrections or alternative HU to electron density tables
can compensate for the limited CBCT image quality and allow dose
calculations to be performed either directly on the CBCT images
[2–4,10] or on CT images adapted to correspond to the anatomy
as seen on the daily CBCT scan [1].
This study investigated the accuracy of dose calculations per-
formed directly on thoracic CBCT images subjected to comprehen-
sive artefact corrections. Following the artefact corrections, dose
calculations were made following the standard CT-based workflow
in a treatment planning system. CBCT based doses were compared
to CT based dose calculations using gamma analysis, as well as
dose statistics.
2. Methods
A total of 21 lung cancer patients treated for non-small cell lung
cancer (NSCLC) with 66Gy in 33 fractions at Odense University
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Hospital between January 2013 and December 2015 were included
in the present study. Based on clinical indications, all patients had
a re-simulation CT (rCT) acquired during treatment.
For each patient, a CBCT scan was acquired for IGRT on the day
of rCT imaging, using our standard clinical protocol for fast 4D
CBCT acquisition on Elekta Synergy or Versa HD accelerators
equipped with XVI R4.5 or R5.0 (Elekta AB, Stockholm, Sweden).
Approximately 750 projection images spanning an arc of 220
degrees were acquired over 2.2 min scan time, using the S20 colli-
mator and F0 filter cassettes. From version 5.0, the XVI software
has a feature called HU calibration, which uses an image of a
homogeneous phantom to correct for some generic artefacts.
While this approach may be successful in recovering CBCT HUs
when a patient is well represented by the homogeneous phantom
used for calibration, it does not ensure a HU-calibrated CBCT scan
for all patients. This feature was not used for reconstruction of any
CBCT scans in the present study, as the feature was not available at
the start of the project.
2.1. Image processing
To allow dose calculations on the CBCT images, each clinical
CBCT image was reconstructed to an average 3D CBCT using the
XVI software. This reconstruction was referred to as the clinical
CBCT. Additionally, an artefact corrected CBCT image was recon-
structed using our previously developed framework [11]. This cor-
rected reconstruction was based on extraction of the clinical CBCT
projection images, which were then corrected for image lag,
detector scatter, patient body scatter and beam hardening, as well
as re-scaling of the pixel values prior to average 3D reconstruction.
Corrections for image lag and detector scatter were performed
using empirical models developed for the flat panel detectors in
our clinic, while corrections for patient body scatter and beam
hardening were based on patient specific Monte Carlo simulations
of primary and scattered photons. The image corrections required
only the original CBCT projection images as well as the initial
planning CT to be performed. CBCT reconstructions of these
improved CBCT images were made using the filtered backprojection
algorithm implemented in the Reconstruction Toolkit [12].
To minimise the small residual anatomical differences between
the CBCT and rCT images acquired on the same day (respiratory
motion, baseline shifts, different positioning on the couch etc.),
the CBCT images were deformably registered against the rCT image
using elastix [13]. Deformable image registrations were made
using the settings of a parameter file obtained from the elastix wiki
website [14], and validated by Klein et al. to have a median residual
mismatch of about 1 mm in the chest region when used for CT to
CT based deformable registration [13].
With the CBCT images acquired in the small field of view on the
XVI system, the CBCT images suffered from truncation of the anat-
omy. To allow dose calculations to be performed, the missing anat-
omy in the CBCT images was padded from the rCT, to which the
CBCT images had already been deformably registered. This last step
was referred to as embedding in the rCT image, and the full process
is shown in Fig. 1. The resulting CBCT images were referred to as
cCBCT (clinical CBCT) and iCBCT (improved CBCT).
2.2. Dose calculations
The original treatment plan (single or dual arc VMAT, planned
on the mid-ventilation phase of a 4D CT) was copied to the rCT,
iCBCT and cCBCT image sets, and dose was calculated on all three
image sets using the collapsed cone algorithm in Pinnacle with a
3 3 3 mm3 dose grid. No plan optimisation was performed in
this recalculation study; only the isocenter, beams, and monitor
units were transferred from the original dose plan. The rCT and
CBCT images were handled in exactly the same way during dose
calculation, using our standard CT to electron density conversion
curve for dose calculation on the rCT and CBCT images.
2.3. Evaluation of calculated doses
The calculated dose distributions were compared using 3D
gamma analysis [15–17] at the 2%/2 mm and 1%/1 mm level. The
rCT based dose was used as reference, while the cCBCT and iCBCT
doses were used as evaluated doses. Dose matrices were resampled
to a finer grid size using trilinear interpolation to a ð0:45 mmÞ3 grid
to allow the strict distance to agreement criteria to be evaluated. A
low dose threshold of 10% of the prescription dose was applied for
the gamma calculations, and the dose difference criterion was cal-
culated using the prescribed dose of 66 Gy. Gamma values were
only calculated within the volume where HU values originated
from the CBCT images, and gamma pass rates (percentage of
gamma values below 1) were used to assess the dose calculation
accuracy of the CBCT images.
To evaluate potential anatomical dependencies of the CBCT
based dose calculation accuracy, gamma pass rates were further
calculated within the delineated PTV, lungs, heart, spinal cord,
and oesophagus. Organs were delineated on the rCT, and due to
the deformable image registration of the cCBCT and iCBCT images,
the structures were directly transferable to the CBCT image sets.
Dose volume histograms (DVHs) were produced to relate the
gamma pass rates to a clinically relevant measure. To simplify
the comparison of dose volume metrics, dose statistics of target
coverage and organs at risk dose volumes were calculated and
Improved CBCTClinical CBCT





Fig. 1. Two CBCT images were prepared for dose calculation for each patient. The
clinical CBCT projection images were subject to extensive image corrections before
being reconstructed to produce the improved CBCT. The clinical and improved CBCT
images were then deformably registered to the re-simulation CT (rCT) acquired on
the same day as the CBCT image projections. To compensate for the truncated field
of view of the CBCT images, the missing anatomy in the deformed CBCT images was
added from the rCT image to produce the cCBCT (clinical) and iCBCT (improved)
images ready for dose calculation.
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compared between the rCT and the CBCT based doses. Dose statis-
tics were chosen according to the constraints used for treatment
planning of NSCLC in our clinic.
2.4. Statistical analysis
To assess the difference between gamma pass rates for doses
calculated on the cCBCT and iCBCT images, statistical analysis
was performed using the Wilcoxon signed rank test. Statistical
analyses were made in Matlab R2014a (The Mathworks Inc, Natick,
MA, USA).
3. Results
An illustrative example of the calculated dose distributions,
dose differences and gamma values is shown in Fig. 2. The patient
shown in Fig. 2 was selected as one of the patients with the largest
difference between the CT and CBCT based doses. The cCBCT based
dose was found too high compared to the reference dose calculated
on the rCT image, which was the general trend observed for the
cCBCT based dose calculations in this study. The iCBCT based dose
distribution was much closer to the reference dose, which was also
reflected in the gamma values being lower for the iCBCT based
dose compared to the cCBCT based dose.
The median gamma pass rate at the 2%/2 mm level in the entire
CBCT volume was 93.1% for the cCBCT based doses and 99.4% for
the iCBCT based doses. The mean of the actual mean gamma value
for the 21 patients at 2%/2 mm was 0.39 ± 0.04 (mean ± standard
error) for the cCBCT based doses, and 0.21 ± 0.01 for the iCBCT
based doses. At 1%/1 mm, the median pass rates were 79.9% and
94.8% for the cCBCT and iCBCT based doses. The mean of the mean
gamma values for all patients was 0.79 ± 0.07 and 0.39 ± 0.03 for
the cCBCT and iCBCT based doses. Wilcoxon signed rank statistics
showed the median gamma pass rates different at p < 0:001 at
both the 2%/2 mm and 1%/1 mm level. Fig. 3 shows the gamma
pass rates for the entire CBCT volume, as well as for individual
organs. It is evident that the image quality improvements applied
to the iCBCT images caused an increase in median gamma pass rate
for all organs at both the 2%/2 mm and 1%/1 mm level, as well as a
reduction in the interquartile range.
Fig. 4 shows a DVH calculated for the same patient as shown in
Fig. 2. As with the dose visualisation, the DVH plot shows that the
cCBCT image resulted in too high doses being calculated. The iCBCT
Fig. 2. Illustrative example dose distribution as calculated on the rCT (a), cCBCT (b), and iCBCT (c) image sets. Dose difference in the example slice is show in (d) (cCBCT-rCT)
and (e) (iCBCT-rCT), while (f)-(g) show the 2%/2 mm gamma values for the cCBCT and iCBCT dose distributions calculated using the rCT dose as reference dose.
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based dose distribution provided DVH curves closer to the rCT
based dose distribution, but still with slightly elevated dose levels
at high doses. This illustrative case was selected as one of the
patients with the largest CBCT to CT DVH differences found
in the studied population. To couple the observed differences in
gamma pass rates to a clinically relevant measure, differences in
dose statistics as used in our clinic during treatment planning are
reported in Fig. 5. Dose statistics were calculated on each rCT
and CBCT based dose, before the rCT based dose statistics were
subtracted from the CBCT based dose statistics. In general, both
sets of CBCT based dose calculations provided dose statistics close
to the rCT based doses, but it is evident that both accuracy and
precision was improved when using the iCBCT images for dose
calculation compared to using the cCBCT images.
4. Discussion
A median 2%/2 mm gamma pass rate of 99:4% for dose calcu-
lated directly on CBCT images of lung cancer patients compared
to dose calculated on a CT image holds promise of an accurate
way to determine the delivered rather than the planned dose to
targets and organs at risk. For lung cancer patients with tumours
that can move between fractions, it is of great interest to be able
to do easy and accurate dose calculations to determine whether
shifts in tumour position and/or patient anatomy in general has
dosimetric effects on the prescribed treatment plan. While this
can be done using repeat CT imaging, the reduced workload of
being able to use CBCT images for dose calculation implies that sys-
tematic dose tracking for all patients is more readily achievable.
Furthermore, the proposed methodology allows retrospective anal-
ysis of the dose delivered to patients who have already completed
treatment since the iCBCT images were reconstructed from the
existing clinical projection images. While no explicit study of
the time stability of the used artefact corrections was carried out,
Fig. 3. Box plots of 2%/2 mm (top) and 1%/1 mm (bottom) gamma pass rates for the entire CBCT field of view as well as for individual structures as delineated on the rCT
images. Wilcoxon signed rank tests indicated statistically significant different median values at p 6 0:01 for all plots, except oesophagus where the 1%/1 mm gamma pass
rates were different at p ¼ 0:03. Whiskers indicate the most extreme value within 1.5 times the interquartile range from the 25th and 75th percentiles.
Fig. 4. Dose-volume histograms for an example patient. Solid line is dose calculated
on the rCT image, long dashed line is dose calculated on the cCBCT image, and short
dashed line is dose calculated on the iCBCT image.
Fig. 5. Box plots of dose statistics differences for the cCBCT and iCBCT based dose calculations. Dose statistics were calculated on each of the CBCT and rCT based doses and
subsequently subtracted. Comparisons were made within the part of the delineated structure that was within the CBCT field of view.
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we note that the corrections have been used with the same calibra-
tion parameters on all linacs in our clinic. Artefact corrections have
thus been performed successfully on XVI systems with detector
panels three to eight years old at the time of image acquisition.
The present study showed that comprehensive artefact correc-
tions in chest CBCT allows for accurate dose calculations to be per-
formed directly on the CBCT images. Deformable registration
between CT and CBCT images acquired on the same day was used
to emphasize the accuracy of dose calculations based on the arte-
fact corrected CBCT images. The residual misalignment following
deformable registration using the same parameters as in the pre-
sent study has been reported to be approximately 1 mm for the
chest region [13] and 2–3 mm in the head and neck region [18]
when registering CT scans against CT scans. The remaining inaccu-
racy in the alignment of the registered image sets motivated the
use of gamma pass rates with distance-to-agreement criteria of 1
and 2 mm, to account for residual misalignment of the images.
The choice of deforming the CBCT images to the rCT images was
made to ensure that the image being deformed was the smaller
volume of the two images being co-registered. If the rCT images
were to be deformed, the part of the rCT image outside the CBCT
FOV would be at risk of running wild during the deformable regis-
tration, as the cost function would only penalise voxels within the
CBCT FOV if they were deformed too much. Individual deformable
registrations of the cCBCT and iCBCT images were made to elimi-
nate any registration bias towards either of the CBCT reconstruc-
tions, and in practice only very minor differences were observed
when comparing the registrations of the cCBCT and iCBCT images
from the same patient.
rCT and CBCT images were acquired on the same day to max-
imise the likeness of the images. It is however noted that the rCT
images were acquired as 4D CT scans with the mid-ventilation
phase used for dose calculation, while the CBCT images were
reconstructed as average 3D scans. This implies that motion arte-
facts were present in the CBCT scans, but not in the rCT scans,
potentially leading to an apparent enlargement and dilution of
the tumour. Motion artefacts could, at least to some extent, explain
why the gamma pass rates were lower for the PTV than for any
other delineated structure, as such artefacts may be observed
around the moving tumour.
While the present study was limited in the comparison of CT
and CBCT images acquired on the same day, it demonstrated high
accuracy of CBCT based dose calculations based on the iCBCT
images. To move forward towards CBCT-only guided ART, a clinical
study should be performed to investigate whether the iCBCT based
dose calculations and potential plan reoptimisations result in
similar clinical decisions as rCT based dose calculations. Further
studies are also needed to assess how the adding of missing anat-
omy from the planning CT image rather than the rCT image affects
the calculated dose–volume histograms and gamma comparisons
between CBCT and CT based dose calculations. However, most
often only small segments of the VMAT treatment pass through
anatomy not contained in the CBCT FOV, and hence we expect only
small changes to arise from using the planning CT for embedding.
Extensions of the proposed methodology to other anatomical sites
should be straight forward, since the chest region is recognised as
the most difficult anatomical site for accuracte dose calculation
[19,20].
Using artefact corrected CBCT images for dose calculation has
the appeal that all existing clinical workflows need not change to
accommodate the iCBCT images, which makes for an easy integra-
tion into any clinic regardless of treatment planning system etc.
Furthermore, no CBCT- or patient specific HU to electron density
conversion curve is required, as the standard CT conversion was
used in the present study. Previous studies have suggested using
deformable registration of the planning CT image to CBCT images
to create a HU-accurate image of the daily anatomy for dose calcu-
lation [1,21], but it remains unclear how this methodology handles
larger anatomical changes as well as changes in lung density
observed during the course of treatment [6]. Using the artefact
corrected CBCT images directly ensures the most accurate image
of the daily anatomy. The present study reports higher gamma pass
rates and smaller dose differences between the iCBCT based dose
and the reference rCT based dose than what has been reported
previously in CBCT recalculation studies of lung cancer patients
[3,22–24].
This study demonstrated that the image quality of chest CBCT
images can be recovered to allow highly accurate CBCT based dose
calculations. Dose of the day calculations as well as dose accumu-
lation studies are now within reach in a clinical environment. The
main limiting factor in realising routine dose accumulation for all
treated lung cancer patients is the delineation of target and organs
at risk on the daily CBCT images. A combination of the present
study and accurate auto-segmentation algorithms could be a
promising way towards a low-cost high-accuracy method provid-
ing an accurate picture of what dose we deliver to every lung
cancer patient treated with radiotherapy.
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